Weans Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 1 Year 6 Months
About Weans Pharmaceuticals
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sidharth Ram, Laxmikant Pani, Bavish Sudharaj, and Four other members serve as directors at the Company.
- CIN/LLPIN
U46497KL2023PTC081968
- Company No.
081968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Weans Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Payyappatt Manju  | Managing Director | 12-Jun-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sidharth Ram | Director | 12-Jun-2023 | Current |
| Laxmikant Pani | Director | 12-Jun-2023 | Current |
| Bavish Sudharaj | Director | 12-Jun-2023 | Current |
| Nellikaparambil Vipin | Director | 12-Jun-2023 | Current |
| Thekkumuri Sreejith | Director | 12-Jun-2023 | Current |
| Parappurath Vishnuraj | Director | 12-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Weans Pharmaceuticals.
Enhance accessibility to Weans Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Weans Pharmaceuticals?
Unlock access to Weans Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gosree Insurance Broking Services Private LimitedActive 8 years 4 monthsSidharth Ram is a mutual person
- Ram Nivas Resorts And Estates Private LimitedActive 17 years 8 months
Sidharth Ram is a mutual person
- Gemini Warehousing And Logistics Private LimitedActive 17 years 11 months
Sidharth Ram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Weans Pharmaceuticals?
Unlock and access historical data on people associated with Weans Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Weans Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weans Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.